PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for SRAMF ( Sisram Medical Ltd ) from 2020 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sisram Medical stock (SRAMF) PE ratio as of Jun 09 2024 is 7.13. More Details

Sisram Medical Ltd (SRAMF) PE Ratio (TTM) Chart

To

Sisram Medical Ltd (SRAMF) PE Ratio (TTM) Historical Data

Total 1028
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 12
Sisram Medical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-09 53.7 2024-04-05 53.7
2024-06-07 53.7 2024-04-04 53.7
2024-06-06 53.7 2024-04-03 53.7
2024-06-05 53.7 2024-04-02 53.7
2024-06-04 53.7 2024-04-01 53.7
2024-06-03 53.7 2024-03-28 53.7
2024-05-31 53.7 2024-03-27 53.7
2024-05-30 53.7 2024-03-26 53.7
2024-05-29 53.7 2024-03-25 53.7
2024-05-28 53.7 2024-03-22 53.7
2024-05-24 53.7 2024-03-21 53.7
2024-05-23 53.7 2024-03-20 53.7
2024-05-22 53.7 2024-03-19 53.7
2024-05-21 53.7 2024-03-18 53.7
2024-05-20 53.7 2024-03-15 53.7
2024-05-17 53.7 2024-03-14 53.7
2024-05-16 53.7 2024-03-13 53.7
2024-05-15 53.7 2024-03-12 53.7
2024-05-14 53.7 2024-03-11 53.7
2024-05-13 53.7 2024-03-08 53.7
2024-05-10 53.7 2024-03-07 53.7
2024-05-09 53.7 2024-03-06 53.7
2024-05-08 53.7 2024-03-05 53.7
2024-05-07 53.7 2024-03-04 53.7
2024-05-06 53.7 2024-03-01 53.7
2024-05-03 53.7 2024-02-29 53.7
2024-05-02 53.7 2024-02-28 53.7
2024-05-01 53.7 2024-02-27 53.7
2024-04-30 53.7 2024-02-26 53.7
2024-04-29 53.7 2024-02-23 53.7
2024-04-26 53.7 2024-02-22 53.7
2024-04-25 53.7 2024-02-21 53.7
2024-04-24 53.7 2024-02-20 53.7
2024-04-23 53.7 2024-02-16 53.7
2024-04-22 53.7 2024-02-15 53.7
2024-04-19 53.7 2024-02-14 53.7
2024-04-18 53.7 2024-02-13 53.7
2024-04-17 53.7 2024-02-12 53.7
2024-04-16 53.7 2024-02-09 53.7
2024-04-15 53.7 2024-02-08 53.7
2024-04-12 53.7 2024-02-07 53.7
2024-04-11 53.7 2024-02-06 53.7
2024-04-10 53.7 2024-02-05 53.7
2024-04-09 53.7 2024-02-02 53.7
2024-04-08 53.7 2024-02-01 53.7

Sisram Medical Ltd (SRAMF) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices, and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.